Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-08-12Clinical Trial Update: Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues [EARLY_Phase 1]
An early-phase 1 trial is investigating experimental PET imaging scans performed before cancer surgery to assess tracer uptake in normal and…
-
CLINICAL_TRIALS trial_result · 2025-08-12Clinical Trial Update: CAR T Cells in Mesothelin-Expressing Breast Cancer [Phase 1]
Phase 1 trial evaluating mesothelin-targeted CAR T cells in breast cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-08-12Clinical Trial Update: SMART-ER: Symptom Monitoring With Patient-reported Outcomes [NA]
The SMART-ER trial evaluating symptom monitoring with patient-reported outcomes in breast cancer was terminated.
-
CLINICAL_TRIALS research · 2025-08-12Clinical Trial Update: Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria [NA]
Memorial Sloan Kettering Cancer Center is conducting a clinical trial in Nigeria to evaluate tablet-based mobile health ultrasound for point…
-
CLINICAL_TRIALS trial_result · 2025-08-12Clinical Trial Update: Comparison of Postoperative Analgesic Effectiveness of Superficial and Deep Serratus Plane Blocks for Mastectomy [NA]
Completed clinical trial comparing superficial versus deep serratus plane blocks for postoperative analgesia after mastectomy.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-08-12Clinical Trial Update: HB1801 Combined Treatment of HER2-positive Breast Cancer [Phase 2]
HB1801 is a Phase 2 study evaluating a combined treatment for HER2-positive breast cancer, with the trial currently not recruiting.
-
CLINICAL_TRIALS research · 2025-08-12Clinical Trial Update: Patient Priorities for Survivorship Care in Older Breast Cancer Survivors [Phase 2]
This Phase 2 clinical trial from UTHealth Houston is exploring patient priorities for survivorship care in older breast cancer survivors and…
-
CLINICAL_TRIALS trial_result · 2025-08-11Clinical Trial Update: Tumor Markers for Efficacy of Dual-Target Therapy in HER2+ Breast Cancer [NA]
This clinical trial update reports completed results evaluating tumor markers for the efficacy of a dual-target therapy in HER2-positive bre…
-
CLINICAL_TRIALS trial_result · 2025-08-11Clinical Trial Update: Trial of ZN-A-1041 Enteric Capsules in Patients With HER2-Positive Advanced Solid Tumors [Phase 1]
Phase 1 trial of ZN-A-1041 enteric capsules in HER2-positive advanced solid tumors has completed. The study enrolled patients with HER2-posi…
-
CLINICAL_TRIALS research · 2025-08-11Clinical Trial Update: PHOENIX DDR/Anti-PD-L1 Trial: A Pre-surgical Window of Opportunity and Post-surgical Adjuvant Biomarker Study of DNA Damage Response Inhibition With or Without Anti-PD-L1 Immunotherapy in Patients With Neoadjuvant Treatment Resistant Residual Triple Negative Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating a DNA damage response inhibitor with or without anti-PD-L1 immunotherapy in patients with neoadjuvant-trea…
-
CLINICAL_TRIALS trial_result · 2025-08-11Clinical Trial Update: Prospective Study on Exemption of Tumor Bed Boost Radiotherapy for pCR Patients After Breast Conserving Surgery With Neoadjuvant Therapy [Phase 2]
A Phase 2 study evaluating whether tumor bed boost radiotherapy can be omitted for patients achieving pathologic complete response after bre…
-
CLINICAL_TRIALS trial_result · 2025-08-11Clinical Trial Update: FErtility, PrEgnancy, contRaceptIon After Breast Cancer in France
A French study assessing fertility, pregnancy, and contraception after breast cancer treatment has completed.
-
CLINICAL_TRIALS research · 2025-08-11Clinical Trial Update: Comparing Patient Reported Outcomes and Clinical Outcomes Based on Different Scar Placement in Patients Undergoing Standard Breast Conserving Surgery for Breast Cancer: The PROM-S Study.
A clinical trial entry (NCT07116642) from The Leeds Teaching Hospitals NHS Trust studying patient-reported and clinical outcomes for differe…
-
CLINICAL_TRIALS research · 2025-08-11Clinical Trial Update: 'ADVANCE' (A Pilot Trial) [Phase 1]
The document notes a Phase 1 pilot trial called ADVANCE for breast cancer that is currently active but not recruiting. It is sponsored by th…
-
CLINICAL_TRIALS research · 2025-08-11Clinical Trial Update: Trastuzumab Rezetecan Combined With Radiotherapy Versus Trastuzumab Rezetecan in the Treatment of HER2-positive Advanced Breast Cancer With Brain Metastases [Phase 2]
This Phase 2 clinical trial is comparing trastuzumab rezetecan with radiotherapy versus trastuzumab rezetecan alone in patients with HER2-po…
-
CLINICAL_TRIALS trial_result · 2025-08-11Clinical Trial Update: Effect of Dietary Counseling and Nutritional Monitoring in Reducing Cancer-related Cachexia Among Female Oncology Patients [NA]
A completed clinical trial evaluating dietary counseling and nutritional monitoring to reduce cancer-related cachexia in female breast cance…
-
CLINICAL_TRIALS research · 2025-08-11Clinical Trial Update: Molecular Breast Imaging (MBI)-Guided Biopsy [NA]
A clinical trial update for a not-yet-recruiting study evaluating Molecular Breast Imaging-guided biopsy for breast cancer detection in dens…
-
CLINICAL_TRIALS research · 2025-08-11Clinical Trial Update: QL1706 With Olaparib for Previously Treated HER2-negative Breast Cancer Patients With Homologous Recombination Deficiency (HRD) [Phase 2]
A Phase 2 trial of QL1706 in combination with Olaparib for previously treated HER2-negative breast cancer patients with homologous recombina…
-
CLINICAL_TRIALS trial_result · 2025-08-08Clinical Trial Update: A Study of Trastuzumab Emtansine in Combination With Atezolizumab or Placebo as a Treatment for Participants With Human Epidermal Growth Factor 2 (HER2)-Positive and Programmed Death-ligand 1 (PD-L1)-Positive Locally Advanced (LABC) or Metastatic Breast Cancer (MBC) [Phase 3]
Phase 3 trial evaluating trastuzumab emtansine in combination with atezolizumab or placebo for HER2-positive, PD-L1-positive locally advance…
-
CLINICAL_TRIALS trial_result · 2025-08-08Clinical Trial Update: Study to Evaluate CCS1477 in Advanced Tumours [Phase 1, Phase 2]
A Phase 1/2 study of CCS1477 has completed, evaluating it in metastatic castration-resistant prostate cancer and metastatic breast cancer, w…
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: Establishment of Molecular Profiling for Individual Clinical Routine Treatment Decision in Early Breast Cancer
Clinical trial update describes establishing molecular profiling to guide individual treatment decisions in early breast cancer. The study i…
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: Role of FGF21 in Breast Cancer
A clinical trial is evaluating the role of fibroblast growth factor 21 (FGF21) in breast cancer, with the study currently not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-08-08Clinical Trial Update: Using an End-of-life Conversation Game to Engage Patients With Cancer in Advance Care Planning: Phase 2 [NA]
Phase 2 trial investigating an end-of-life conversation game to engage cancer patients in advance care planning; the study is currently acti…
-
CLINICAL_TRIALS trial_result · 2025-08-08Clinical Trial Update: [18F]FES PET/CT in Endocrine Refractory Breast Cancer [Phase 2]
Phase 2 trial evaluating [18F]fluoroestradiol PET/CT imaging in estrogen receptor-positive breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-08-07Clinical Trial Update: Efficacy and Safety of T-DXd in Patients With HER2-positive and HER2-low Metastatic Breast Cancer: a Real-world Study
This real-world study updates the efficacy and safety of trastuzumab deruxtecan (T-DXd) in patients with HER2-positive and HER2-low metastat…